Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Julie Bellemans
Profile
Projects
Publications
Activities
Awards & Distinctions
3
Results
2022
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
Jonas Steenbrugge
Julie Bellemans
Niels Vander Elst
Kristel Demeyere
Josephine De Vliegher
Timothy Perera
Olivier De Wever
Wim Van Den Broeck
Ward De Spiegelaere
Niek Sanders
et al.
A1
Journal Article
in
ONCOIMMUNOLOGY
2022
One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer
Jonas Steenbrugge
Julie Bellemans
Niels Vander Elst
Kristel Demeyere
Niek Sanders
Evelyne Meyer
C3
Conference
2022
Progression of canine mammary tumors is associated with an immunosuppressed microenvironment
Jonas Steenbrugge
Julie Bellemans
Lennert Heirman
Aurelie De Roover
Kristel Demeyere
Hilde De Rooster
Evelyne Meyer
C3
Conference
2022